| scholarly article | Q13442814 |
| P2093 | author name string | Adams H | |
| Merouze F | |||
| Haller L | |||
| Dago A | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | trypanosomiasis | Q2443552 |
| African trypanosomiasis | Q203133 | ||
| P304 | page(s) | 94-99 | |
| P577 | publication date | 1986-01-01 | |
| P1433 | published in | American Journal of Tropical Medicine and Hygiene | Q15766943 |
| P1476 | title | Clinical and pathological aspects of human African trypanosomiasis (T. b. gambiense) with particular reference to reactive arsenical encephalopathy | |
| P478 | volume | 35 |
| Q64122665 | A New Generation of Minor-Groove-Binding-Heterocyclic Diamidines That Recognize G·C Base Pairs in an AT Sequence Context |
| Q36110834 | A substance P antagonist, RP-67,580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei |
| Q92446512 | Clinical Study on the Melarsoprol-Related Encephalopathic Syndrome: Risk Factors and HLA Association |
| Q61809084 | Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis |
| Q28477304 | Clinical presentation of T.b. rhodesiense sleeping sickness in second stage patients from Tanzania and Uganda |
| Q39294611 | Erythrina abyssinica prevents meningoencephalitis in chronic Trypanosoma brucei brucei mouse model |
| Q35345427 | From health advice to taboo: community perspectives on the treatment of sleeping sickness in the Democratic Republic of Congo, a qualitative study |
| Q37929054 | Human African trypanosomiasis in endemic populations and travellers |
| Q30351707 | In search of new lead compounds for trypanosomiasis drug design: a protein structure-based linked-fragment approach. |
| Q92733893 | MRI findings of the brain in human African trypanosomiasis: a case series and review of the literature |
| Q30419162 | Protein crystallography and infectious diseases |
Search more.